Global Colloidal Nanoparticles Market Growth 2025-2031

Publication ID:

LPI05253222

Publication Date:

May 6, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Colloidal Nanoparticles market size is predicted to grow from US$ 174 million in 2025 to US$ 234 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.
Colloidal nanoparticles are nanometer-sized particles (typically 1鈥�100 nm) that are suspended in a liquid medium, forming a colloidal dispersion. These nanoparticles exhibit unique physical, chemical, optical, and electronic properties due to their high surface-area-to-volume ratio and quantum effects, making them valuable in various scientific and industrial applications.
United States market for Colloidal Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Colloidal Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Colloidal Nanoparticles is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Colloidal Nanoparticles players cover BBI Solutions, Cytodiagnostics, Fortis Life Sciences, Meliorum Technologies, TANAKA PRECIOUS METAL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐olloidal Nanoparticles Industry Forecast鈥� looks at past sales and reviews total world Colloidal Nanoparticles sales in 2024, providing a comprehensive analysis by region and market sector of projected Colloidal Nanoparticles sales for 2025 through 2031. With Colloidal Nanoparticles sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Colloidal Nanoparticles industry.
This Insight Report provides a comprehensive analysis of the global Colloidal Nanoparticles landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Colloidal Nanoparticles portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Colloidal Nanoparticles market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Colloidal Nanoparticles and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Colloidal Nanoparticles.
This report presents a comprehensive overview, market shares, and growth opportunities of Colloidal Nanoparticles market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Silver Nanoparticles
Gold Nanoparticles
Others
Segmentation by Application:
Imaging
Targeted Drug Delivery
Proton Therapy
In Vitro Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BBI Solutions
Cytodiagnostics
Fortis Life Sciences
Meliorum Technologies
TANAKA PRECIOUS METAL
Merck KGaA
Nanopartz
CD Bioparticles
Nano Labs
Nanocs
Key Questions Addressed in this Report
What is the 10-year outlook for the global Colloidal Nanoparticles market?
What factors are driving Colloidal Nanoparticles market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Colloidal Nanoparticles market opportunities vary by end market size?
How does Colloidal Nanoparticles break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Colloidal Nanoparticles Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Colloidal Nanoparticles by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Colloidal Nanoparticles by Country/Region, 2020, 2024 & 2031
2.2 Colloidal Nanoparticles Segment by Type
2.2.1 Silver Nanoparticles
2.2.2 Gold Nanoparticles
2.2.3 Others
2.3 Colloidal Nanoparticles Sales by Type
2.3.1 Global Colloidal Nanoparticles Sales Market Share by Type (2020-2025)
2.3.2 Global Colloidal Nanoparticles Revenue and Market Share by Type (2020-2025)
2.3.3 Global Colloidal Nanoparticles Sale Price by Type (2020-2025)
2.4 Colloidal Nanoparticles Segment by Application
2.4.1 Imaging
2.4.2 Targeted Drug Delivery
2.4.3 Proton Therapy
2.4.4 In Vitro Testing
2.4.5 Others
2.5 Colloidal Nanoparticles Sales by Application
2.5.1 Global Colloidal Nanoparticles Sale Market Share by Application (2020-2025)
2.5.2 Global Colloidal Nanoparticles Revenue and Market Share by Application (2020-2025)
2.5.3 Global Colloidal Nanoparticles Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Colloidal Nanoparticles Breakdown Data by Company
3.1.1 Global Colloidal Nanoparticles Annual Sales by Company (2020-2025)
3.1.2 Global Colloidal Nanoparticles Sales Market Share by Company (2020-2025)
3.2 Global Colloidal Nanoparticles Annual Revenue by Company (2020-2025)
3.2.1 Global Colloidal Nanoparticles Revenue by Company (2020-2025)
3.2.2 Global Colloidal Nanoparticles Revenue Market Share by Company (2020-2025)
3.3 Global Colloidal Nanoparticles Sale Price by Company
3.4 Key Manufacturers Colloidal Nanoparticles Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Colloidal Nanoparticles Product Location Distribution
3.4.2 Players Colloidal Nanoparticles Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Colloidal Nanoparticles by Geographic Region
4.1 World Historic Colloidal Nanoparticles Market Size by Geographic Region (2020-2025)
4.1.1 Global Colloidal Nanoparticles Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Colloidal Nanoparticles Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Colloidal Nanoparticles Market Size by Country/Region (2020-2025)
4.2.1 Global Colloidal Nanoparticles Annual Sales by Country/Region (2020-2025)
4.2.2 Global Colloidal Nanoparticles Annual Revenue by Country/Region (2020-2025)
4.3 Americas Colloidal Nanoparticles Sales Growth
4.4 APAC Colloidal Nanoparticles Sales Growth
4.5 Europe Colloidal Nanoparticles Sales Growth
4.6 Middle East & Africa Colloidal Nanoparticles Sales Growth
5 Americas
5.1 Americas Colloidal Nanoparticles Sales by Country
5.1.1 Americas Colloidal Nanoparticles Sales by Country (2020-2025)
5.1.2 Americas Colloidal Nanoparticles Revenue by Country (2020-2025)
5.2 Americas Colloidal Nanoparticles Sales by Type (2020-2025)
5.3 Americas Colloidal Nanoparticles Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Colloidal Nanoparticles Sales by Region
6.1.1 APAC Colloidal Nanoparticles Sales by Region (2020-2025)
6.1.2 APAC Colloidal Nanoparticles Revenue by Region (2020-2025)
6.2 APAC Colloidal Nanoparticles Sales by Type (2020-2025)
6.3 APAC Colloidal Nanoparticles Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Colloidal Nanoparticles by Country
7.1.1 Europe Colloidal Nanoparticles Sales by Country (2020-2025)
7.1.2 Europe Colloidal Nanoparticles Revenue by Country (2020-2025)
7.2 Europe Colloidal Nanoparticles Sales by Type (2020-2025)
7.3 Europe Colloidal Nanoparticles Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Colloidal Nanoparticles by Country
8.1.1 Middle East & Africa Colloidal Nanoparticles Sales by Country (2020-2025)
8.1.2 Middle East & Africa Colloidal Nanoparticles Revenue by Country (2020-2025)
8.2 Middle East & Africa Colloidal Nanoparticles Sales by Type (2020-2025)
8.3 Middle East & Africa Colloidal Nanoparticles Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Colloidal Nanoparticles
10.3 Manufacturing Process Analysis of Colloidal Nanoparticles
10.4 Industry Chain Structure of Colloidal Nanoparticles
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Colloidal Nanoparticles Distributors
11.3 Colloidal Nanoparticles Customer
12 World Forecast Review for Colloidal Nanoparticles by Geographic Region
12.1 Global Colloidal Nanoparticles Market Size Forecast by Region
12.1.1 Global Colloidal Nanoparticles Forecast by Region (2026-2031)
12.1.2 Global Colloidal Nanoparticles Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Colloidal Nanoparticles Forecast by Type (2026-2031)
12.7 Global Colloidal Nanoparticles Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 BBI Solutions
13.1.1 BBI Solutions Company Information
13.1.2 BBI Solutions Colloidal Nanoparticles Product Portfolios and Specifications
13.1.3 BBI Solutions Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BBI Solutions Main Business Overview
13.1.5 BBI Solutions Latest Developments
13.2 Cytodiagnostics
13.2.1 Cytodiagnostics Company Information
13.2.2 Cytodiagnostics Colloidal Nanoparticles Product Portfolios and Specifications
13.2.3 Cytodiagnostics Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Cytodiagnostics Main Business Overview
13.2.5 Cytodiagnostics Latest Developments
13.3 Fortis Life Sciences
13.3.1 Fortis Life Sciences Company Information
13.3.2 Fortis Life Sciences Colloidal Nanoparticles Product Portfolios and Specifications
13.3.3 Fortis Life Sciences Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fortis Life Sciences Main Business Overview
13.3.5 Fortis Life Sciences Latest Developments
13.4 Meliorum Technologies
13.4.1 Meliorum Technologies Company Information
13.4.2 Meliorum Technologies Colloidal Nanoparticles Product Portfolios and Specifications
13.4.3 Meliorum Technologies Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Meliorum Technologies Main Business Overview
13.4.5 Meliorum Technologies Latest Developments
13.5 TANAKA PRECIOUS METAL
13.5.1 TANAKA PRECIOUS METAL Company Information
13.5.2 TANAKA PRECIOUS METAL Colloidal Nanoparticles Product Portfolios and Specifications
13.5.3 TANAKA PRECIOUS METAL Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 TANAKA PRECIOUS METAL Main Business Overview
13.5.5 TANAKA PRECIOUS METAL Latest Developments
13.6 Merck KGaA
13.6.1 Merck KGaA Company Information
13.6.2 Merck KGaA Colloidal Nanoparticles Product Portfolios and Specifications
13.6.3 Merck KGaA Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck KGaA Main Business Overview
13.6.5 Merck KGaA Latest Developments
13.7 Nanopartz
13.7.1 Nanopartz Company Information
13.7.2 Nanopartz Colloidal Nanoparticles Product Portfolios and Specifications
13.7.3 Nanopartz Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nanopartz Main Business Overview
13.7.5 Nanopartz Latest Developments
13.8 CD Bioparticles
13.8.1 CD Bioparticles Company Information
13.8.2 CD Bioparticles Colloidal Nanoparticles Product Portfolios and Specifications
13.8.3 CD Bioparticles Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 CD Bioparticles Main Business Overview
13.8.5 CD Bioparticles Latest Developments
13.9 Nano Labs
13.9.1 Nano Labs Company Information
13.9.2 Nano Labs Colloidal Nanoparticles Product Portfolios and Specifications
13.9.3 Nano Labs Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nano Labs Main Business Overview
13.9.5 Nano Labs Latest Developments
13.10 Nanocs
13.10.1 Nanocs Company Information
13.10.2 Nanocs Colloidal Nanoparticles Product Portfolios and Specifications
13.10.3 Nanocs Colloidal Nanoparticles Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nanocs Main Business Overview
13.10.5 Nanocs Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂